Evidence map›Paper›PMID 35934279›Full record

ArticleThe ocular surface2022

Benzalkonium chloride, a common ophthalmic preservative, compromises rat corneal cold sensitive nerve activity.

Evguenia Ivakhnitskaia, Vladislav Souboch, Valentina Dallacasagrande, Kamila Mizerska, Elizaveta Souboch, Joy Sarkar, Victor H Guaiquil, Kuei Y Tseng, Harumitsu Hirata, Mark I Rosenblatt

Open access · hybridAbstract read
In one paragraph

Article in The ocular surface, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED.Translational vision science & technology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Evguenia IvakhnitskaiaDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA.
Vladislav SoubochDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA.
Valentina DallacasagrandeDepartment of Ophthalmology, Weill Cornell Medical College, New York, NY, 10075, USA.
Kamila MizerskaDepartment of Ophthalmology, Weill Cornell Medical College, New York, NY, 10075, USA; Department of Neuroscience, University of Wisconsin, Madison, WI, 53706, USA.
Elizaveta SoubochDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA.
Joy SarkarDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA.
Victor H GuaiquilDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA.
Kuei Y TsengDepartment of Anatomy and Cell Biology, University of Illinois-Chicago, Chicago, IL, 60612, USA.
Harumitsu HirataDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA; Department of Ophthalmology, Weill Cornell Medical College, New York, NY, 10075, USA.
Mark I RosenblattDepartment of Ophthalmology and Visual Sciences, University of Illinois-Chicago (UIC), Chicago, IL, 60612, USA. Electronic address: mrosenbl@uic.edu.
University of Illinois Urbana-Champaign · USCornell University · USUniversity of Illinois Chicago · USUniversity of Wisconsin–Madison · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
Mechanisms of Corneal Nerve RepairR01EY018594 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSENBLATT, MARK I · 2010 to 2014
$2.1M
Tear hyperosmolarity, corneal nerves and dry eye diseaseR01EY023555 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HIRATA, HARUMITSU · 2013 to 2017
$2.1M
Mechanisms of Corneal Nerve RepairR01EY027912 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROSENBLATT, MARK I · 2017 to 2020
$1.6M
Correlations of structure and function in regenerating corneal nervesF30EY029578 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI IVAKHNITSKAIA, EVGUENIA · 2019 to 2022
$203k
NEI NIH HHS F30 EY029578NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY018594NEI NIH HHS R01 EY023555NEI NIH HHS R01 EY027912
6 · The paper itself

Abstract

purposeCorneal nerves comprise the densest sensory network in the body. Dysfunction of the corneal cold sensitive neurons (CSN) is implicated in ophthalmic disorders, including Dry Eye Disease, the most common ocular surface disorder. The preservative Benzalkonium chloride (BAK) and the mydriatic agent Phenylephrine hydrochloride (PHE) are considered to be inactive at the level of the CSNs. The purpose of this study is to test the impacts of continuous exposures to BAK or PHE at their clinically used concentrations on corneal nerve structure and function.

methodsIn vivo extracellular electrophysiology of the rat trigeminal ganglion was used to monitor CSN functional response to stimuli mimicking physiological states and stressors of the cornea. Corneal nerve structure was evaluated by immunostaining.

resultsAmong the tested stimuli, cold probe receptive field stimulation and hyperosmolar stress were the most sensitive methods of detecting activity changes. CSN activity was attenuated after 30 min exposure to either PHE or BAK. After an hour-long washout period, BAK-treated neurons failed to recover activity while PHE-treated neurons showed signs of functional recovery. Intraepithelial nerve density was reduced and nerve fragmentation was increased in BAK-treated corneas, while PHE exposure left corneal nerves structurally intact.

conclusionsOur study suggests that prolonged ocular instillations of BAK or PHE alter CSN activity through two different processes - irreversible neuronal damage in the case of BAK vs. reversible attenuation in the case of PHE.

Indexed as

Benzalkonium CompoundsDry Eye SyndromesAnimalsCorneaOphthalmic SolutionsPreservatives, PharmaceuticalRatsBenzalkonium CompoundsOphthalmic SolutionsPreservatives, PharmaceuticalBenzalkonium chlorideCold sensitive nervesCorneaIn vivo electrophysiologyNerve damageNerve functionNerve structureSensation

Identifiers

PMID35934279
PMCPMC12327410
OpenAlexW4289830303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.